Visteon
VC
$120.00
+5.44%
Visteon Corporation is a global automotive supplier specializing in the design, engineering, and manufacturing of advanced cockpit electronics and connected car solutions for original equipment vehicle manufacturers. The company operates as a key technology partner within the Auto - Parts industry, focusing on high-growth areas like digital instrument clusters, domain controllers, infotainment systems, and battery management systems. The current investor narrative centers on the company's strategic pivot towards high-value electronics and software, capitalizing on the automotive industry's shift towards electrification, digitalization, and autonomous driving features, though this transition is being closely watched against a backdrop of potential cyclical pressures in the broader automotive sector.…
VC
Visteon
$120.00
Investment Opinion: Should I buy VC Today?
Rating: Hold. The core thesis is that Visteon presents a compelling valuation case undermined by near-term fundamental headwinds, creating a 'wait-and-see' scenario where the risk/reward is balanced. Supporting evidence for this Hold rating includes: 1) A discounted forward P/E of 11.40x, which is low both historically and relative to its sector's typical multiples for tech-oriented suppliers. 2) Strong financial backing from $334M in TTM FCF and a pristine balance sheet (D/E of 0.34), providing a margin of safety. 3) Bullish analyst consensus with an average EPS estimate of $12.73, implying confidence in a earnings recovery. 4) A recent technical rebound showing +22% over 3 months, suggesting the market may be beginning to look past the worst of the Q4 weakness. The rating is contingent on monitoring two key risks: further margin erosion and a failure of revenue to re-accelerate. This Hold would upgrade to a Buy if the company demonstrates a clear reversal in gross and net margins in the next quarter, or if the stock price retreats to the mid-$90s, offering a larger margin of safety. It would downgrade to a Sell if revenue growth turns negative or if TTM FCF shows sustained decline. Based on the current data, the stock appears fairly valued, pricing in the existing challenges but offering little premium for a successful technology pivot until execution improves.
Sign up to view all
VC 12-Month Price Forecast
The outlook for VC is balanced with a tilt towards caution. The company's strong financial position acts as a buffer, but the recent dramatic collapse in profitability cannot be ignored and is the primary overhang. The base case of a gradual, uneven recovery is most probable, leading to range-bound trading. The stance is neutral because the attractive valuation is counteracted by fundamental deterioration; we need to see evidence that the margin issue is transitory. An upgrade to bullish would require consecutive quarters of margin improvement and revenue re-acceleration. A downgrade to bearish would be triggered by a breakdown below $95 on worsening fundamentals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Visteon's 12-month outlook, with a consensus price target around $156.00 and implied upside of +30.0% versus the current price.
Average Target
$156.00
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$96 - $156
Analyst target range
Visteon is covered by a moderate number of analysts, with 6 providing estimates. The institutional ratings show a bullish lean, with recent actions including 'Outperform' from Baird and RBC Capital, 'Buy' from UBS, and 'Overweight' from Wells Fargo, against more neutral stances from JP Morgan and Barclays. The consensus recommendation is overweight/buy, and the average EPS estimate for the period is $12.73, with a revenue estimate of $4.57 billion, though a specific consensus price target is not provided in the data to calculate implied upside. The target range among analysts is not explicitly given, but the variance in EPS estimates is relatively tight, with a low of $12.46 and a high of $12.96. This narrow spread suggests a higher degree of conviction and lower uncertainty regarding near-term financial performance. The pattern of recent ratings indicates stability, with most firms reaffirming their existing positions throughout early 2026, signaling that the analyst community's view has not shifted dramatically despite the stock's price volatility, which could be interpreted as underlying fundamental confidence.
Bulls vs Bears: VC Investment Factors
The evidence presents a classic value-versus-momentum tension. The bull case is anchored in a strong financial foundation (robust FCF, solid balance sheet), deeply discounted valuation multiples, and supportive analyst sentiment. The bear case is driven by alarming near-term fundamental deterioration, specifically the severe compression in profitability and stalling revenue growth. Currently, the bearish evidence from deteriorating fundamentals carries more weight, as it directly challenges the core earnings power that underpins the valuation. The single most important tension in the investment debate is whether the recent margin collapse is a temporary, company-specific issue or a structural signal of competitive and pricing pressures that will prevent a return to historical profitability levels. The resolution of this margin trajectory will be the primary determinant of the stock's direction.
Bullish
- Strong Free Cash Flow & Balance Sheet: The company generates robust free cash flow, with TTM FCF of $334 million, providing ample internal funding for growth and shareholder returns. A strong current ratio of 1.80 and a low debt-to-equity of 0.34 underpin financial flexibility and a lower risk profile.
- Attractive Valuation Multiples: Visteon trades at a trailing P/E of 12.87x and a forward P/E of 11.40x, which is in the lower mid-range of its historical spectrum. The EV/EBITDA of 5.22x and PS ratio of 0.69 appear low, potentially offering a value opportunity if fundamentals stabilize.
- Analyst Consensus is Bullish: The analyst community leans bullish with recent 'Outperform' and 'Buy' ratings from Baird, RBC, and UBS. The narrow EPS estimate range ($12.46-$12.96) suggests high conviction and lower uncertainty regarding near-term performance.
- Recent Technical Rebound: The stock has shown a strong 1-month surge of +19.63% and a 3-month gain of +22.00%, significantly outperforming the SPY by 17.86 points over three months. This signals a potential momentum recovery from oversold conditions earlier in the year.
Bearish
- Severe Profitability Compression: Q4 2025 net margin collapsed to 1.48% from 12.99% in Q4 2024, with gross margin falling to 12.87% from 14.29% in Q3 2025. This sharp decline raises serious questions about the company's pricing power and earnings sustainability.
- Revenue Growth Has Stalled: Q4 2025 revenue grew a mere 0.96% YoY and has declined sequentially from a peak of $969 million in Q2 2025 to $948 million. This stagnation indicates potential headwinds in automotive production or customer demand.
- High Volatility & Recent Drawdown: The stock has a beta of 1.159, making it 16% more volatile than the market, and has experienced a significant max drawdown of -34.41% from its 52-week high. Elevated short interest, with a short ratio of 5.11, reflects persistent negative sentiment.
- Cyclical Sector Exposure: As an auto parts supplier, Visteon is inherently exposed to the cyclical pressures of the automotive industry. The recent margin pressure and revenue softness may be early signs of a broader sector slowdown impacting its technology pivot narrative.
VC Technical Analysis
The stock is in a pronounced downtrend from its 52-week highs, with a 1-year price change of +39.63% but a 6-month change of only +3.44%, indicating significant recent weakness. As of the latest close at $110.85, the stock is trading at approximately 74% of its 52-week range ($78.82 to $129.10), positioning it closer to the middle of the band but having retreated substantially from recent highs, suggesting momentum has stalled and the stock is consolidating after a strong prior run. Recent momentum shows a sharp divergence, with a strong 1-month surge of +19.63% and a 3-month gain of +22.00%, which starkly contrasts with the flattish 6-month performance, signaling a potential rebound or recovery attempt from oversold conditions earlier in the year, as evidenced by the stock's 17.86 points of relative strength versus the SPY over the last three months. Key technical support is anchored at the 52-week low of $78.82, while immediate resistance sits at the 52-week high of $129.10. A sustained breakout above the recent highs near $114 would signal a resumption of the longer-term uptrend, whereas a breakdown below the March 2026 lows near $84 would confirm a bearish continuation. The stock's beta of 1.159 indicates it is approximately 16% more volatile than the broader market, which is relevant for risk-aware investors given the stock's recent drawdown of -34.41% and elevated short interest reflected in a short ratio of 5.11.
Beta
1.27
1.27x market volatility
Max Drawdown
-34.4%
Largest decline past year
52-Week Range
$83-$129
Price range past year
Annual Return
+32.6%
Cumulative gain past year
| Period | VC Return | S&P 500 |
|---|---|---|
| 1m | +5.8% | -0.2% |
| 3m | +36.8% | +14.0% |
| 6m | +23.8% | +7.8% |
| 1y | +32.6% | +25.3% |
| ytd | +23.9% | +9.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
VC Fundamental Analysis
Revenue growth has stagnated recently, with Q4 2025 revenue of $948 million representing a mere 0.96% year-over-year increase, and a sequential decline from the $969 million reported in Q2 2025. The quarterly trend shows revenue peaked in Q2 2025 and has since softened, indicating potential headwinds in automotive production or customer demand, which tempers the near-term growth investment case. Segment data, though not dated, suggests the Instrument Cluster business ($440 million) is the largest revenue contributor, followed by Audio & Infotainment ($112 million) and Body & Electrification ($109 million). The company remains profitable but with notable margin volatility; Q4 2025 net income was $14 million on a net margin of 1.48%, a sharp compression from the 12.99% net margin in Q4 2024. Gross margin for the latest quarter was 12.87%, down from 14.29% in Q3 2025, indicating pressure on pricing or product mix, while operating margin contracted to 7.17% from 8.51% over the same period. The trajectory shows profitability is under pressure, moving away from the higher margins seen in late 2024, which raises questions about the company's ability to maintain earnings power in a potentially tougher operating environment. Balance sheet health is solid, with a strong current ratio of 1.80 and a conservative debt-to-equity ratio of 0.34. The company generates robust free cash flow, with TTM FCF of $334 million, providing ample internal funding for growth initiatives and shareholder returns, as evidenced by $50 million in stock repurchases in Q4 2025. Return on equity of 12.82% is respectable, and with $773 million in cash at the end of Q4 2025, the company maintains significant liquidity, underpinning its financial flexibility and lower risk profile.
Quarterly Revenue
$948000000.0B
2025-12
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
+0.12%
Latest Quarter
Free Cash Flow
$334000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is VC Overvalued?
Given a positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 12.87x, while the forward P/E is 11.40x, indicating the market expects modest earnings growth, as the forward multiple implies a slight compression or stabilization relative to the trailing figure. The gap between the two is not wide, suggesting consensus expectations are for steady, rather than explosive, near-term profit expansion. Compared to sector averages, Visteon trades at a discount on a Price/Sales basis, with a PS ratio of 0.69, though direct industry average comparisons are not provided in the data. The EV/EBITDA of 5.22x appears low, potentially reflecting the market's cautious view on cyclicality and margin pressures within the auto parts sector. The stock's valuation premium or discount justification hinges on its technology positioning versus traditional suppliers, but current multiples seem to price in the recent profitability challenges. Historically, the stock's current trailing P/E of 12.87x sits well below its own historical range observed in the data, which has seen peaks above 50x during periods of low earnings and troughs near 5x. This places the current valuation in the lower mid-range of its historical spectrum, suggesting the market is not pricing in overly optimistic expectations and may have already discounted the recent margin compression, potentially offering a value opportunity if fundamentals stabilize.
PE
12.9x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -77x~132x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
5.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the company's deteriorating profitability and earnings volatility. The Q4 2025 net margin of 1.48% represents a severe 1,151 basis point contraction year-over-year, indicating significant pressure on the bottom line. While the balance sheet is strong with $773 million in cash, the core risk is that this margin compression becomes persistent, eroding the company's ability to generate meaningful earnings growth to justify even its modest valuation. Revenue concentration in the cyclical automotive sector, evidenced by the recent 0.96% YoY growth, adds to the operational uncertainty. Market & Competitive Risks are elevated due to Visteon's valuation being caught between a value and growth narrative. Trading at a forward P/E of 11.40x, the market is not pricing in high growth, but a further de-rating is possible if sector-wide cyclical fears intensify. The stock's beta of 1.159 means it will amplify any broader market downturns. Competitive risks are inherent as the company pivots to high-value electronics, facing pressure from both traditional suppliers and new tech entrants, which may be contributing to the observed margin squeeze. Worst-Case Scenario involves a continuation of the current negative fundamental trends: sustained margin pressure combines with a cyclical downturn in auto production, leading to consecutive earnings misses and analyst downgrades. This could trigger a re-test of the 52-week low of $78.82. From the current price of $110.85, this scenario implies a realistic downside of approximately -29%. A break below this support could lead to further declines towards the $70s, especially if the company's cash generation weakens, undermining its primary financial strength.
FAQ
The key risks are, in order of severity: 1) Profitability Risk: The dramatic compression in net margin from 12.99% to 1.48% YoY could persist or worsen. 2) Cyclical & Demand Risk: Revenue growth has stalled at 0.96% YoY, exposing the company to downturns in the auto industry. 3) Volatility Risk: With a beta of 1.159, the stock is 16% more volatile than the market, amplifying losses in downturns, as seen in its -34.41% drawdown. 4) Execution Risk: The company's pivot to high-value electronics faces intense competition, and failure to gain share could limit long-term growth.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $105 and $120, assuming revenue meets analyst estimates of ~$4.57B and margins stabilize. The Bull Case (25% probability) targets $125-$135, driven by successful margin recovery and new contract wins. The Bear Case (15% probability) warns of a drop to $80-$95 if cyclical pressures intensify and margins fail to recover. The base case is most likely, hinging on the assumption that the company's strong cash flow can support it through a period of challenged profitability.
VC appears fairly valued to slightly undervalued based on traditional metrics, but the valuation accurately reflects its current challenges. Its forward P/E of 11.40x and EV/EBITDA of 5.22x are low compared to many industrial and tech suppliers, suggesting a discount. However, this discount is justified by the recent profitability crisis. The market is pricing in subdued growth and margin recovery, not a rapid expansion. Therefore, it is fairly valued given the near-term uncertainty, but undervalued if the company can successfully execute its technology pivot and restore margins.
VC is a conditional buy for patient, value-oriented investors. At a forward P/E of 11.4x with a strong balance sheet, it offers a margin of safety, and analyst consensus is bullish with an average EPS estimate of $12.73. However, the severe recent margin compression (net margin fell to 1.48% in Q4) presents a significant near-term risk. It is a good buy for those who believe the profitability collapse is temporary and are willing to wait for a recovery, but not suitable for investors seeking stable growth or low volatility.
VC is more suitable for a medium- to long-term investment horizon of 2-3 years. Its value proposition relies on a recovery in fundamentals and the maturation of its technology initiatives, which will take multiple quarters to materialize. The stock's high beta (1.159) and recent volatility make it a poor candidate for short-term trading unless based on specific catalyst timing (e.g., earnings). Long-term investors can benefit from the current valuation discount if the turnaround occurs, but they must be prepared for significant price swings along the way. A minimum holding period of 18 months is suggested to allow the investment thesis to play out.